When exploring the landscape of peptide synthesis and specialized manufacturing, the PolyPeptide Group stands out as a significant entity. As an enthusiast who has followed the evolution of this field, I have often looked into the operational structure of major industry players. A common question that arises for those researching this sector is, "Where is the polypeptide group headquarters?"
The Central Hub: PolyPeptide Group AG
The core of the organization is located in Switzerland. Specifically, the headquarters in 24 Neuhofstrasse Baar, Zug Switzerland (Zip: 6340 Baar, Switzerland) serves as the primary base for the PolyPeptide Group. It is important to distinguish this from other industry entities, such as the organization with headquarters in Bubendorf, Switzerland, which is a separate entity.
For those looking for official contact points, the Headquarters at Neuhofstrasse 24, Baar, Zug, 6340, Switzerland is the cent PolyPeptide is a specialized Contract Development & Manufacturing Organization (CDMO) for peptide and oligonucleotide-based active pharmaceutical ingredients ( ral administrative node. While many associate the brand with its long history dating bac With headquarters in Bubendorf, Switzerland, and affiliates in Europe and the US, Bachem works on a global scale and holds a leading position in the field of k to 1952 in Malmö, Sweden, the current corporate structure reflects a globalized CDMO (Contract Development & Manufacturing Organization).
Global Operational Network
The company’s reach extends far beyond its Swiss roots. As a specialized Contract Development & Manufacturing Organization, they maintain a robust network of facilities. Their operational footprint includes:
* Europe: Beyond the Swiss base, they operate in Braine-l'Alleud, Belgium, as well as sites in Strasbourg, France, and their historical roots in Malmö, Sweden.
* United States: The PolyPeptide presence in the US is substantial. Key locations include 365 Maple Ave, Torrance, CA 90503 Jobs list and the 9395 Cabot Drive, San Diego, CA Apr 20, 2022 — Oligonucleotide Supplier, Fill-Finish and Formulation, Peptides. San Diego, CA, USA. 9395 Cabot Drive, San Diego, CA, 92126, USA. 0 reviews. , 92126 facility. For those trying to reach their US offices, the Office: 858-455-0300 line is a frequently referenced contact point.
* India: A major part of their growth strategy involves the Ambernath, India facility. Located at Plot No K 28, Near Additional MIDC, Anand Nagar, Ambernath (East), this site has seen significant investment to expand its Ambernath facility in India, highlighting their commitment to global supply chains.
Industry Context and Evolution
The PolyPeptide brand is synonymous with high-quality, GMP-grade production. Whether discussing peptide synthesis or the manufacturing of complex active ingredients, the company is a focused Contract Development & Manufacturing Organization that has navigated the industry since 1952.
From my perspective as someone tracking these developments, the shift toward a more integrated global model—incorporating sites from Torrance, S PolyPeptide - 2026 Company Profile & Competitors an Diego, Braine-l'Alleud, Malmö, Ambernath, and Strasbourg—demonstrates a clear focus on scale and technical expertise. They have successfully transitioned from local manufacturing roots to a publicly traded entity on the SIX Swiss Exchange (PPGN).
Summary of Key Information
For researchers and industry followers, tracking the PolyPeptide Group requires keeping an eye on their regulatory and physical hubs. While some older records might point to 19 Dammstrasse, Zug, 6300, CH, the current primary registration remains at the Neuhofstrasse address.
Understa With headquarters in Bubendorf, Switzerland, and affiliates in Europe and the US, Bachem works on a global scale and holds a leading position in the field of nding this organizational structure helps in appreciating how PolyPeptide's capabilities ar PolyPeptide Group's main headquarters is located at 24 Neuhofstrasse Baar, Zug Switzerland. The company has employees across 4 continents, including EuropeNorth e distributed across four continents. By maintaining a network that spans from K-28, Additional MIDC Area, Ambernath (East) to the Torrance and San Diego sites, they continue to solidify their position in the specialized market of peptide manufacturing. Whether you are reviewing their history or their latest facility upgrades, it is clear that the PolyPeptide Group remains a cornerstone of the global manufacturing landscape.